{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T13:30:45Z","timestamp":1791898245399,"version":"4.3.4"},"reference-count":64,"publisher":"The Journal of Rheumatology","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Rheumatol"],"accepted":{"date-parts":[[2024,1,23]]},"published-print":{"date-parts":[[2024,5]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Vaccination against preventable infections is important for the management of rheumatic diseases (RDs). This study assessed the vaccination coverage and predictors among patients with RDs using real-world data from Israel.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective cross-sectional study, based on a Maccabi Healthcare Services database, included adult patients diagnosed with rheumatoid arthritis (RA), psoriatic arthritis (PsA), and systemic lupus erythematosus (SLE), as of April 30, 2019. Age-specific vaccination coverage for influenza (past year), pneumococcal (23-valent pneumococcal polysaccharide vaccine [PPSV23] and\/or 13-valent pneumococcal conjugate vaccine [PCV13]), and live-attenuated herpes zoster (HZ) vaccines (past 5 years) was reported. Logistic regression was used to investigate predictors of vaccination.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The study included 14,528 patients (RA: n = 6932; PsA: n = 4395; SLE: n = 1951; &gt; 1 condition: n = 1250). Influenza vaccine coverage among patients with RA, PsA, and SLE was 45.1%, 36.2%, and 33.7%, respectively. For PPSV23, corresponding rates were 19.6%, 16.2%, and 12.6%, respectively. In the elderly population (\u2265 65 years), 63.2% had influenza vaccine in the past year and 83.4% had a PPSV23 vaccine in the past 5 years or at age \u2265 65. For PCV13 and HZ, coverage in the overall study population was low at 4.8% and 3.6%, respectively. Central residence and treatment with corticosteroids and biologic or targeted synthetic disease-modifying antirheumatic drugs within the past 5 years were significant predictors of vaccination coverage across all vaccines (\n                      <jats:italic>P<\/jats:italic>\n                      &lt; 0.05). Other predictors varied by vaccine, including female sex (influenza, PPSV23, PCV13), age (influenza, PPSV23), chronic comorbidities (influenza, PPSV23, PCV13), shorter disease duration (PCV13), and high socioeconomic status (PCV13, HZ).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study demonstrated suboptimal coverage of influenza, pneumococcal, and HZ vaccination in patients with RA, PsA, and SLE, in particular among younger adults in Israel.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3899\/jrheum.2023-0867","type":"journal-article","created":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T08:25:15Z","timestamp":1706775915000},"page":"505-516","source":"Crossref","is-referenced-by-count":14,"title":["Real-World Coverage With Influenza, Pneumococcal, and Herpes Zoster Vaccines Among Patients With Rheumatic Diseases in a Nationwide Healthcare Plan"],"prefix":"10.3899","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5193-4207","authenticated-orcid":false,"given":"Victoria","family":"Furer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Weil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Chodik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shera Ann","family":"Slav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiran Naftelberg","family":"Blonder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonit","family":"Fisher-Shoval","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moran","family":"Barak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1873-8930","authenticated-orcid":false,"given":"Ori","family":"Elkayam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2262","published-online":{"date-parts":[[2024,2,1]]},"reference":[{"key":"2024050105200875000_51.5.505.1","doi-asserted-by":"publisher","DOI":"10.1002\/art.10524"},{"key":"2024050105200875000_51.5.505.2","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2019-001041"},{"key":"2024050105200875000_51.5.505.3","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1093\/rheumatology\/keaa478","article-title":"The risk of infections in adult patients with systemic lupus erythematosus: systematic review and meta-analysis","volume":"60","author":"Pego-Reigosa","year":"2021","journal-title":"Rheumatology"},{"key":"2024050105200875000_51.5.505.4","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2010.128637"},{"key":"2024050105200875000_51.5.505.5","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kes305"},{"key":"2024050105200875000_51.5.505.6","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1007\/s10067-022-06450-2","article-title":"Prevalence and risk factors of herpes zoster infection in patients with rheumatic diseases not receiving biologic or targeted therapies","volume":"42","author":"Mok","year":"2023","journal-title":"Clin Rheumatol"},{"key":"2024050105200875000_51.5.505.7","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2474-13-158"},{"key":"2024050105200875000_51.5.505.8","doi-asserted-by":"publisher","DOI":"10.1136\/jech-2011-200168"},{"key":"2024050105200875000_51.5.505.9","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofu024"},{"key":"2024050105200875000_51.5.505.10","doi-asserted-by":"publisher","DOI":"10.1177\/0961203314543918"},{"key":"2024050105200875000_51.5.505.11","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/civ803"},{"key":"2024050105200875000_51.5.505.12","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.jbspin.2017.05.012","article-title":"Pneumococcal infection in patients with systemic lupus erythematosus","volume":"85","author":"Schurder","year":"2018","journal-title":"Joint Bone Spine"},{"key":"2024050105200875000_51.5.505.13","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofw205"},{"key":"2024050105200875000_51.5.505.14","doi-asserted-by":"crossref","first-page":"ofaa005","DOI":"10.1093\/ofid\/ofaa005","article-title":"Risk factors for herpes zoster infection: a meta-analysis","volume":"7","author":"Marra","year":"2020","journal-title":"Open Forum Infect Dis"},{"key":"2024050105200875000_51.5.505.15","doi-asserted-by":"crossref","first-page":"ii24","DOI":"10.1093\/rheumatology\/keaa895","article-title":"The safety of JAK-1 inhibitors","volume":"60","author":"Clarke","year":"2021","journal-title":"Rheumatology"},{"key":"2024050105200875000_51.5.505.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2017.10.009"},{"key":"2024050105200875000_51.5.505.17","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1002\/art.39670","article-title":"Risk of herpes zoster in autoimmune and inflammatory diseases: implications for vaccination","volume":"68","author":"Yun","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"2024050105200875000_51.5.505.18","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2021-000574"},{"key":"2024050105200875000_51.5.505.19","doi-asserted-by":"publisher","DOI":"10.1177\/0961203312470186"},{"key":"2024050105200875000_51.5.505.20","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2019-001035"},{"key":"2024050105200875000_51.5.505.21","doi-asserted-by":"crossref","first-page":"3666","DOI":"10.1093\/rheumatology\/keaa078","article-title":"Effectiveness of inactivated influenza vaccine in autoimmune rheumatic diseases treated with disease-modifying anti-rheumatic drugs","volume":"59","author":"Nakafero","year":"2020","journal-title":"Rheumatology"},{"key":"2024050105200875000_51.5.505.22","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13075-016-1207-7","article-title":"The 23-valent pneumococcal polysaccharide vaccine in patients with rheumatoid arthritis: a double-blinded, randomized, placebo-controlled trial","volume":"19","author":"Izumi","year":"2017","journal-title":"Arthritis Res Ther"},{"key":"2024050105200875000_51.5.505.23","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2010.144451"},{"key":"2024050105200875000_51.5.505.24","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.160685"},{"key":"2024050105200875000_51.5.505.25","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-215882"},{"key":"2024050105200875000_51.5.505.26","unstructured":"Centers for Disease Control and Prevention . Pneumococcal vaccine recommendations. [Internet. Accessed January 26, 2024.] Available from: https:\/\/www.cdc.gov\/vaccines\/vpd\/pneumo\/hcp\/recommendations.html"},{"key":"2024050105200875000_51.5.505.27","unstructured":"Israeli Ministry of Health . [National vaccine guideline. Procedures and guidelines: vaccination briefing.] [Website in Hebrew. Internet. Accessed January 26, 2024.] Available from: https:\/\/www.health.gov.il\/Subjects\/vaccines\/Pages\/tadrich_Chisunim.aspx"},{"key":"2024050105200875000_51.5.505.28","unstructured":"Elderly adults. Quality indicators. [Website in Hebrew. Internet. Accessed on October 21 2023]. Available from: https:\/\/israelhealthindicators-org.translate.goog\/areas\/%D7%9E%D7%91%D7%95%D7%92%D7%A8%D7%99%D7%9D-%D7%91%D7%A0%D7%99-65\/?mID=2&subject=10&mCode=2&_x_tr_sl=iw&_x_tr_tl=en&_x_tr_hl=en&_x_tr_pto=sc"},{"key":"2024050105200875000_51.5.505.29","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1016\/j.vaccine.2017.03.031","article-title":"The herd effects of infant PCV7\/PCV13 sequential implementation on adult invasive pneumococcal disease, six years post implementation; a nationwide study in Israel","volume":"35","author":"Regev-Yochay","year":"2017","journal-title":"Vaccine"},{"key":"2024050105200875000_51.5.505.30","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1016\/j.vaccine.2015.01.065","article-title":"Low rate of influenza and pneumococcal vaccine coverage in rheumatoid arthritis: data from the international COMORA cohort","volume":"33","author":"Hmamouchi","year":"2015","journal-title":"Vaccine"},{"key":"2024050105200875000_51.5.505.31","doi-asserted-by":"crossref","first-page":"e0153848","DOI":"10.1371\/journal.pone.0153848","article-title":"Influenza and pneumococcal vaccination uptake in patients with rheumatoid arthritis treated with immunosuppressive therapy in the UK: A retrospective cohort study using data from the clinical practice research datalink","volume":"11","author":"Costello","year":"2016","journal-title":"PLoS ONE"},{"key":"2024050105200875000_51.5.505.32","doi-asserted-by":"crossref","first-page":"162","DOI":"10.55563\/clinexprheumatol\/cpu6r9","article-title":"Prevention and management of herpes zoster in patients with rheumatoid arthritis and psoriatic arthritis: a clinical review","volume":"40","author":"Winthrop","year":"2022","journal-title":"Clin Exp Rheumatol"},{"key":"2024050105200875000_51.5.505.33","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2015.01.002"},{"key":"2024050105200875000_51.5.505.34","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1080\/03009742.2016.1242774","article-title":"Factors associated with influenza and pneumococcal vaccine uptake among rheumatoid arthritis patients in Denmark invited to participate in a pneumococcal vaccine trial (Immunovax_RA)","volume":"46","author":"Nguyen","year":"2017","journal-title":"Scand J Rheumatol"},{"key":"2024050105200875000_51.5.505.35","unstructured":"National Insurance Institute . [Health maintenance organizations survey 2018-2019.] [Article in Hebrew. Internet. Accessed February 8, 2024.] Available from: www.btl.gov.il\/Publications\/survey\/Documents\/seker317\/seker_317.pdf"},{"key":"2024050105200875000_51.5.505.36","unstructured":"Central Bureau of Statistics . Census of population and housing 1995 \u2013 statistical abstract of Israel \u2013 vol. 49. [Internet. Accessed January 26, 2024.] Available from: https:\/\/www.cbs.gov.il\/en\/publications\/Pages\/1998\/Census-of-Population-and-Housing-1995-statistical-Abstract-of-Israel-1998-No49.aspx"},{"key":"2024050105200875000_51.5.505.37","doi-asserted-by":"publisher","DOI":"10.1023\/B:EJEP.0000006635.36802.c8"},{"key":"2024050105200875000_51.5.505.38","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2010.08.002"},{"key":"2024050105200875000_51.5.505.39","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2014.6634"},{"key":"2024050105200875000_51.5.505.40","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.114.03718"},{"key":"2024050105200875000_51.5.505.41","doi-asserted-by":"crossref","first-page":"A389","DOI":"10.1016\/j.jval.2014.08.2665","article-title":"The use of clinical data repository for the establishment of an osteoporosis registry in a large health organization in israel: epidemiologic and pharmaepidemiologic findings","volume":"17","author":"Goldshtein","year":"2014","journal-title":"Value Health"},{"key":"2024050105200875000_51.5.505.42","first-page":"23","article-title":"An assessment of the completeness and timeliness of the Israel national cancer registry","volume":"23","author":"Moore","year":"2021","journal-title":"Isr Med Assoc J"},{"key":"2024050105200875000_51.5.505.43","unstructured":"National Program for Quality Indicators in community healthcare in Israel [report]. Available from: https:\/\/israelhealthindicators.org\/areas\/"},{"key":"2024050105200875000_51.5.505.44","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.3390\/vaccines10101654","article-title":"Vaccination coverage among immunocompromised patients in a large health maintenance organization: findings from a novel computerized registry","volume":"10","author":"Shapiro Ben David","year":"2022","journal-title":"Vaccines"},{"key":"2024050105200875000_51.5.505.45","doi-asserted-by":"publisher","DOI":"10.1186\/ar3497"},{"key":"2024050105200875000_51.5.505.46","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s00296-016-3608-y","article-title":"Low vaccination rates among patients with rheumatoid arthritis in a German outpatient clinic","volume":"37","author":"Krasselt","year":"2017","journal-title":"Rheumatol Int"},{"key":"2024050105200875000_51.5.505.47","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.181376"},{"key":"2024050105200875000_51.5.505.48","first-page":"161","article-title":"Understanding vaccination rates and attitudes among patients with rheumatoid arthritis","volume":"22","author":"Sandler","year":"2016","journal-title":"Am J Manag Care"},{"key":"2024050105200875000_51.5.505.49","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.7326\/M20-6928","article-title":"The safety and immunologic effectiveness of the live varicella-zoster vaccine in patients receiving tumor necrosis factor inhibitor therapy: a randomized controlled trial","volume":"174","author":"Curtis","year":"2021","journal-title":"Ann Intern Med"},{"key":"2024050105200875000_51.5.505.50","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/acr.25045","article-title":"2022 American College of Rheumatology guideline for vaccinations in patients with rheumatic and musculoskeletal diseases","volume":"75","author":"Bass","year":"2023","journal-title":"Arthritis Care Res"},{"key":"2024050105200875000_51.5.505.51","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2007.081703"},{"key":"2024050105200875000_51.5.505.52","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keq297"},{"key":"2024050105200875000_51.5.505.53","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1007\/s00296-016-3516-1","article-title":"Influenza and pneumococcal vaccination in patients with rheumatoid arthritis in comparison with age- and sex-matched controls: results of a claims data analysis","volume":"36","author":"Luque Ramos","year":"2016","journal-title":"Rheumatol Int"},{"key":"2024050105200875000_51.5.505.54","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1186\/s12891-016-1187-4","article-title":"A large two-centre study in to rates of influenza and pneumococcal vaccination and infection burden in rheumatoid arthritis in the UK","volume":"17","author":"Subesinghe","year":"2016","journal-title":"BMC Musculoskelet Disord"},{"key":"2024050105200875000_51.5.505.55","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1002\/acr2.11427","article-title":"Predictors of influenza vaccination in early rheumatoid arthritis 2017-2021: results from the Canadian early arthritis cohort","volume":"4","author":"Ta","year":"2022","journal-title":"ACR Open Rheumatol"},{"key":"2024050105200875000_51.5.505.56","unstructured":"Israeli Medical Association . Inadequate healthcare and general inequity in the periphery. [Internet. Accessed January 26, 2024.] Available from: https:\/\/www.ima.org.il\/eng\/ViewContent.aspx?CategoryId=6177"},{"key":"2024050105200875000_51.5.505.57","doi-asserted-by":"crossref","first-page":"18","DOI":"10.4078\/jrd.22.0012","article-title":"Physicians\u2019 agreement on and implementation of the 2019 European Alliance of Associations for Rheumatology vaccination guideline: an international survey","volume":"30","author":"Seo","year":"2023","journal-title":"J Rheum Dis"},{"key":"2024050105200875000_51.5.505.58","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s10067-020-05059-7","article-title":"Understanding factors associated with vaccine uptake and vaccine hesitancy in patients with rheumatoid arthritis: a scoping literature review","volume":"40","author":"Boucher","year":"2021","journal-title":"Clin Rheumatol"},{"key":"2024050105200875000_51.5.505.59","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keu531"},{"key":"2024050105200875000_51.5.505.60","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jbspin.2015.11.005","article-title":"Influenza and pneumococcal vaccine coverage in 584 patients taking biological therapy for chronic inflammatory joint: a retrospective study","volume":"83","author":"Brocq","year":"2016","journal-title":"Joint Bone Spine"},{"key":"2024050105200875000_51.5.505.61","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.150984"},{"key":"2024050105200875000_51.5.505.62","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s10067-020-05435-3","article-title":"A multimodal intervention increases influenza vaccine uptake in rheumatoid arthritis","volume":"40","author":"Valerio","year":"2021","journal-title":"Clin Rheumatol"},{"key":"2024050105200875000_51.5.505.63","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.3390\/vaccines11081355","article-title":"A nationwide digital multidisciplinary intervention aimed at promoting pneumococcal vaccination in immunocompromised patients","volume":"11","author":"Shapiro Ben David","year":"2023","journal-title":"Vaccines"},{"key":"2024050105200875000_51.5.505.64","doi-asserted-by":"publisher","DOI":"10.1186\/s13584-021-00440-6"}],"container-title":["The Journal of Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.3899\/jrheum.2023-0867","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T11:04:32Z","timestamp":1714561472000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jrheum.org\/lookup\/doi\/10.3899\/jrheum.2023-0867"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,1]]},"references-count":64,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,5,1]]},"published-print":{"date-parts":[[2024,5]]}},"alternative-id":["10.3899\/jrheum.2023-0867"],"URL":"https:\/\/doi.org\/10.3899\/jrheum.2023-0867","relation":{},"ISSN":["0315-162X","1499-2752"],"issn-type":[{"value":"0315-162X","type":"print"},{"value":"1499-2752","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,1]]}}}